The use of serology for trachoma surveillance: Current status and priorities for future investigation

doi:10.1371/journal.pntd.0008316

Review

. 2020 Sep 24;14(9):e0008316.

doi: 10.1371/journal.pntd.0008316. eCollection 2020 Sep.

The use of serology for trachoma surveillance: Current status and priorities for future investigation

Diana L Martin ¹, Martha Idalí Saboyà-Díaz ², Aida Abashawl ³, Wondu Alemayeh ^{3

4}, Sarah Gwyn ¹, Pamela J Hooper ⁵, Jeremy Keenan ^{6

7}, Khumbo Kalua ⁸, Celia Landmann Szwarcwald ⁹, Scott Nash ¹⁰, Catherine Oldenburg ^{6

7

11}, Sheila K West ¹², Michael White ¹³, Anthony W Solomon ¹⁴

Affiliations

¹ Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
² Communicable Diseases and Environmental Determinants of Health Department, Pan-American Health Organization, Washington, DC, United States of America.
³ Berhan Public Health and Eye Care Consultancy, Addis Ababa, Ethiopia.
⁴ The Fred Hollows Foundation, Addis Ababa, Ethiopia.
⁵ International Trachoma Initiative, Task Force for Global Health, Decatur, Georgia, United States of America.
⁶ Francis I. Proctor Foundation, University of California at San Francisco, San Francisco, California, United States of America.
⁷ Department of Ophthalmology, University of California at San Francisco, San Francisco, California, United States of America.
⁸ Department of Ophthalmology, University of Malawi, College of Medicine Blantyre, Malawi.
⁹ Institute of Scientific and Technological Communication and information in Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
¹⁰ Trachoma Control Program, The Carter Center, Atlanta, Georgia, United States of America.
¹¹ Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California, United States of America.
¹² Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
¹³ Malaria: Parasites & Hosts, Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France.
¹⁴ Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.

PMID: 32970672
PMCID: PMC7514076
DOI: 10.1371/journal.pntd.0008316

Review

The use of serology for trachoma surveillance: Current status and priorities for future investigation

Diana L Martin et al. PLoS Negl Trop Dis. 2020.

. 2020 Sep 24;14(9):e0008316.

doi: 10.1371/journal.pntd.0008316. eCollection 2020 Sep.

Authors

Diana L Martin ¹, Martha Idalí Saboyà-Díaz ², Aida Abashawl ³, Wondu Alemayeh ^{3

4}, Sarah Gwyn ¹, Pamela J Hooper ⁵, Jeremy Keenan ^{6

7}, Khumbo Kalua ⁸, Celia Landmann Szwarcwald ⁹, Scott Nash ¹⁰, Catherine Oldenburg ^{6

7

11}, Sheila K West ¹², Michael White ¹³, Anthony W Solomon ¹⁴

Affiliations

¹ Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
² Communicable Diseases and Environmental Determinants of Health Department, Pan-American Health Organization, Washington, DC, United States of America.
³ Berhan Public Health and Eye Care Consultancy, Addis Ababa, Ethiopia.
⁴ The Fred Hollows Foundation, Addis Ababa, Ethiopia.
⁵ International Trachoma Initiative, Task Force for Global Health, Decatur, Georgia, United States of America.
⁶ Francis I. Proctor Foundation, University of California at San Francisco, San Francisco, California, United States of America.
⁷ Department of Ophthalmology, University of California at San Francisco, San Francisco, California, United States of America.
⁸ Department of Ophthalmology, University of Malawi, College of Medicine Blantyre, Malawi.
⁹ Institute of Scientific and Technological Communication and information in Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
¹⁰ Trachoma Control Program, The Carter Center, Atlanta, Georgia, United States of America.
¹¹ Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California, United States of America.
¹² Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
¹³ Malaria: Parasites & Hosts, Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France.
¹⁴ Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.

PMID: 32970672
PMCID: PMC7514076
DOI: 10.1371/journal.pntd.0008316

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

1. Solomon A.W., et al., Strategies for control of trachoma: observational study with quantitative PCR. Lancet, 2003. 362(9379): p. 198–204. 10.1016/S0140-6736(03)13909-8 - DOI - PubMed
1. West E.S., et al., Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community. Invest Ophthalmol Vis Sci, 2005. 46(1): p. 83–7. 10.1167/iovs.04-0327 - DOI - PMC - PubMed
1. Bailey R., et al., The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol Infect, 1999. 123(3): p. 479–86. 10.1017/s0950268899003076 - DOI - PMC - PubMed
1. Gambhir M., et al., The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control. PLoS Negl Trop Dis, 2009. 3(6): p. e462 10.1371/journal.pntd.0000462 - DOI - PMC - PubMed
1. West S.K., et al., Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol, 2001. 8(2–3): p. 137–44. 10.1076/opep.8.2.137.4158 - DOI - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

001/WHO_/World Health Organization/International

LinkOut - more resources

Full Text Sources

[1] Solomon A.W., et al., Strategies for control of trachoma: observational study with quantitative PCR. Lancet, 2003. 362(9379): p. 198–204. 10.1016/S0140-6736(03)13909-8 - DOI - PubMed

[2] Solomon A.W., et al., Strategies for control of trachoma: observational study with quantitative PCR. Lancet, 2003. 362(9379): p. 198–204. 10.1016/S0140-6736(03)13909-8 - DOI - PubMed

[3] West E.S., et al., Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community. Invest Ophthalmol Vis Sci, 2005. 46(1): p. 83–7. 10.1167/iovs.04-0327 - DOI - PMC - PubMed

[4] West E.S., et al., Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community. Invest Ophthalmol Vis Sci, 2005. 46(1): p. 83–7. 10.1167/iovs.04-0327 - DOI - PMC - PubMed

[5] Bailey R., et al., The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol Infect, 1999. 123(3): p. 479–86. 10.1017/s0950268899003076 - DOI - PMC - PubMed

[6] Bailey R., et al., The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol Infect, 1999. 123(3): p. 479–86. 10.1017/s0950268899003076 - DOI - PMC - PubMed

[7] Gambhir M., et al., The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control. PLoS Negl Trop Dis, 2009. 3(6): p. e462 10.1371/journal.pntd.0000462 - DOI - PMC - PubMed

[8] Gambhir M., et al., The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control. PLoS Negl Trop Dis, 2009. 3(6): p. e462 10.1371/journal.pntd.0000462 - DOI - PMC - PubMed

[9] West S.K., et al., Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol, 2001. 8(2–3): p. 137–44. 10.1076/opep.8.2.137.4158 - DOI - PubMed

[10] West S.K., et al., Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol, 2001. 8(2–3): p. 137–44. 10.1076/opep.8.2.137.4158 - DOI - PubMed

Account

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The use of serology for trachoma surveillance: Current status and priorities for future investigation

Affiliations

The use of serology for trachoma surveillance: Current status and priorities for future investigation

Authors

Affiliations

Conflict of interest statement

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources